Table 1.
Participant demographics
| Treatment | N | GMFCS | Age | Gender | Height | Mass |
|---|---|---|---|---|---|---|
| I/II/III | y + mo | F:M | meters | kg | ||
| BTA | 52 | 18/19/15 | 6 + 10 (2 + 11) |
19:33 | 1.15 (0.16) |
21.3 (8.7) |
| SDR | 38 | 11/23/4 | 9 + 4 (2 + 0) |
20:18 | 1.33 (0.10) |
29.7 (6.2) |
| SEMLS | 57 | 20/17/20 | 12 + 2 (3 + 1) |
23:34 | 1.45 (0.16) |
39.3 (14.8) |
| TD | 31 | – | 9 + 3 (2 + 9) |
17:14 | 1.38 (0.17) |
33.8 (13.3) |
NOTE. Values are average (1 SD) or as otherwise indicated
N Number of Participants, GMFCS Gross Motor Function Classification System, y + mo Years + Months, F Female, M Male, BTA Botulinum Toxin Type-A Injection,
SDR Selective Dorsal Rhizotomy, SEMLS Single Event Multi-Level Orthopaedic Surgery, TD Typically-Developing Children